Yanrong Luo

Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study

K. Nackaerts, H. Groen, N. Reinmuth, 2021 .

First case report of a NUP98-PMX1 rearrangement in de novo acute myeloid leukemia and literature review

Jianmin Yang, G. Tang, Jianmin Wang, 2021, BMC Medical Genomics.

Aplastic Anemia Preconditioned with Fludarabine, Cyclophosphamide, and Anti-Thymocyte Globulin

Jianmin Yang, G. Tang, Jie Chen, 2019, Annals of transplantation.

Preconditioning with fludarabine, busulfan and cytarabine versus standard BuCy2 for patients with acute myeloid leukemia: a prospective, randomized phase II study

Jianmin Yang, G. Tang, Jie Chen, 2018, Bone Marrow Transplantation.

Sequential autologous and allogeneic stem cell transplantation for treatment of primary plasma cell leukemia: A case report

Jianmin Yang, G. Tang, A. Huang, 2023, Molecular and clinical oncology.

Effect of sustained measurable residue disease negativity and post‐remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults

Jie Chen, X. Ni, Yanrong Luo, 2024, Cancer medicine.

Comparison of stem cell transplantation using unrelated, haploidentical, and sibling donors for patients with acquired severe aplastic anemia : A single center, retrospective, cohort study

Jianmin Yang, Jie Chen, Ziwei Wang, 2023, Transplantation and Cellular Therapy.